The most controversial case in the Supreme Court last year was Burwell v. Hobby Lobby. In that case, business owners with a sincere religious belief against assisting in what they regard as the taking of human life asserted a right under the federal Religious Freedom Restoration Act (RFRA) not to […]
Of all its cases last term, the Supreme Court’s decision in Burwell v. Hobby Lobby attracted the most strident criticism. The Court held that Hobby Lobby, a family-owned, for-profit corporation that operates a successful chain of craft stores, could not be compelled to pay for health insurance covering abortion-inducing contraceptive […]
Last April, soon after I accepted Stanford’s offer to join its faculty, I received a call from Robert Bauer and Ben Ginsberg, the lawyers who had represented President Barack Obama and Governor Mitt Romney in the 2012 presidential election. They had been tasked by the president with chairing a bipartisan […]
The combination of technology advances and cost-cutting pressures from clients is triggering a major transformation in the core practices of business law. In particular, the past decade has witnessed the emergence and significant improvement of software that designs, drafts, reads (visualizes and operationalizes), and manages contract documents. These innovations have […]
Many would say that for a lawyer nothing is more wonderful than the thrill of freeing the innocent or walking an unjustly incarcerated defendant out of prison. And indeed it is a wonderful thrill. A lawyer obviously cares about the individual deeply and passionately, cares about justice and doing the […]
Even as unemployment rates soared during the Great Depression, FDR’s relief and social security programs faced attacks in Congress and the courts on the legitimacy of federal aid to the growing population of poor. In response, New Dealers pointed to a long tradition—dating back to 1790 and now largely forgotten—of […]
It is easy to talk about the growth of Stanford Law School’s clinical program by focusing on numbers. We now have 10 clinical programs; 10 faculty members leading clinics; 9 clinical instructors; 7 support staff; 130 students enrolled in clinics each year; and 20,000 square feet of dedicated clinical space. […]
In the year 1800, slavery was normal. European countries used international law to authorize and justify the ownership of human beings. In the first decade of the nineteenth century, an estimated 609,000 slaves arrived in the New World. Within a relatively short time span, however, things began to change. In […]
A leading expert on the legal, ethical, and social issues surrounding health law and the biosciences, Hank Greely (BA ’74) specializes in the implications of new biomedical technologies, especially those related to neuroscience, genetics, and stem cell research. He is chair of California’s Human Stem Cell Research Advisory Committee and served from 2007-2010 as co-director of the Law and Neuroscience Project, funded by the MacArthur Foundation. Here Professor Greely offers his insights into the growing field of law and biosciences.
Jeffrey Skilling led Enron from 1997 to 2001. During his tenure Enron grew into one of the most successful companies in the United States, primarily as an energy trading company. Many of its employees invested their life savings in Enron stock, and investors flocked to the company; Enron became the darling of the investment community and its officers joined the inner circle of industry elite.